DE2329412C3 - Suspension mit einem Gehalt an beschichteten Methenaminmandelatteilchen - Google Patents

Suspension mit einem Gehalt an beschichteten Methenaminmandelatteilchen

Info

Publication number
DE2329412C3
DE2329412C3 DE2329412A DE2329412A DE2329412C3 DE 2329412 C3 DE2329412 C3 DE 2329412C3 DE 2329412 A DE2329412 A DE 2329412A DE 2329412 A DE2329412 A DE 2329412A DE 2329412 C3 DE2329412 C3 DE 2329412C3
Authority
DE
Germany
Prior art keywords
methenamine
suspension
particles
almondate
coated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2329412A
Other languages
German (de)
English (en)
Other versions
DE2329412A1 (de
DE2329412B2 (de
Inventor
James Ronald Dover Draper
Frank William Morristown Goodhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE2329412A1 publication Critical patent/DE2329412A1/de
Publication of DE2329412B2 publication Critical patent/DE2329412B2/de
Application granted granted Critical
Publication of DE2329412C3 publication Critical patent/DE2329412C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Medicines Containing Plant Substances (AREA)
DE2329412A 1972-07-03 1973-06-08 Suspension mit einem Gehalt an beschichteten Methenaminmandelatteilchen Expired DE2329412C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26837172A 1972-07-03 1972-07-03

Publications (3)

Publication Number Publication Date
DE2329412A1 DE2329412A1 (de) 1974-01-31
DE2329412B2 DE2329412B2 (de) 1978-07-13
DE2329412C3 true DE2329412C3 (de) 1979-04-19

Family

ID=23022703

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2329412A Expired DE2329412C3 (de) 1972-07-03 1973-06-08 Suspension mit einem Gehalt an beschichteten Methenaminmandelatteilchen

Country Status (8)

Country Link
US (1) US3780170A (US06589383-20030708-C00041.png)
JP (1) JPS4955816A (US06589383-20030708-C00041.png)
AU (1) AU469349B2 (US06589383-20030708-C00041.png)
CA (1) CA1007988A (US06589383-20030708-C00041.png)
DE (1) DE2329412C3 (US06589383-20030708-C00041.png)
DK (1) DK133083C (US06589383-20030708-C00041.png)
FR (1) FR2190466B1 (US06589383-20030708-C00041.png)
GB (1) GB1379534A (US06589383-20030708-C00041.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4349529A (en) * 1980-04-14 1982-09-14 E. R. Squibb & Sons, Inc. Diagnostic and therapeutic capsules and method of producing
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
EP0559897B1 (en) * 1990-11-30 1998-03-04 Yamanouchi Pharmaceutical Co. Ltd. Quick release coated preparation
TW241194B (US06589383-20030708-C00041.png) * 1991-12-27 1995-02-21 Takeda Pharm Industry Co Ltd
US6818597B2 (en) * 2000-04-21 2004-11-16 Benchmark Research & Technology, Inc. Suspensions of water soluble polymers in surfactant free non-aqueous solvents
US6743756B2 (en) * 2001-01-26 2004-06-01 Benchmark Research And Technology, Inc. Suspensions of particles in non-aqueous solvents

Also Published As

Publication number Publication date
AU5707973A (en) 1974-12-19
FR2190466B1 (US06589383-20030708-C00041.png) 1977-07-15
DK133083B (da) 1976-03-22
AU469349B2 (en) 1976-02-12
US3780170A (en) 1973-12-18
DK133083C (da) 1976-08-23
DE2329412A1 (de) 1974-01-31
JPS4955816A (US06589383-20030708-C00041.png) 1974-05-30
DE2329412B2 (de) 1978-07-13
GB1379534A (en) 1975-01-02
FR2190466A1 (US06589383-20030708-C00041.png) 1974-02-01
CA1007988A (en) 1977-04-05

Similar Documents

Publication Publication Date Title
DE2418345C2 (de) Pharmazeutisches Mittel für äußerliche Anwendung an menschlicher Haut
AT396329B (de) Pharmazeutische granulate und verfahren zu ihrer herstellung
DE3124014A1 (de) Aluminiumibuprofensuspensionen
DE2329412C3 (de) Suspension mit einem Gehalt an beschichteten Methenaminmandelatteilchen
DE1106454B (de) UEberzugsmittel fuer Arzneistoffe
DE3538429A1 (de) Pulver mit gesteuerter freisetzung, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zusammensetzung
DE3013839A1 (de) Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
DE68906765T2 (de) Zusammensetzung mit einem extrakt,das durch extraktion mit einem wasserhaltigen organischen loesungsmittel erhalten wurde und verfahren zu seiner herstellung.
US3879511A (en) Tasteless methenamine mandelate in a stabilized vegetable oil suspension
DE60100389T2 (de) Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung
DE2149699A1 (de) Pharmazeutische Zusammensetzungen mit verzoegerter Wirkstoff-Freisetzung
EP2632443B1 (de) Herstellung orodispersibler filme
DE60017881T2 (de) Trinkbare pharmazeutische suspension von ibuprofen
DE69003960T2 (de) Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten.
DE2434849C2 (de) Herzstärkende Dosierungseinheit mit Gelatinekapsel
EP1572344B1 (de) Pellets und verfahren zu seiner herstellung
DE1617522A1 (de) Verfahren zur Herstellung einer Arzneimittelzubereitung
DE3509741A1 (de) Orale dosierungsform von etoposid
AT368880B (de) Verfahren zur herstellung eines zur weiterverarbeitung zu einer waesserigen suspension dienenden wasserunloeslichen trockeninstantpr[parates
DE1617309C3 (de) Verfahren zur Herstellung von pharmazeutischen Präparaten mit Vitamingehalt
DE1467788C (de) Wässrige oder wässrig alkoholische peroral einzunehmende Arzneimittellosung
DE1467919C (de) Verwendung des Aluminiumsalzes der O-Acetylsalicylsäure in festen Arzneizubereitungsformen mit Depot-Wirkung
DE557608C (de) Verfahren zur Herstellung von Duenndarmpillen und -pastillen
DE3003147A1 (de) Suppositorium mit einem gehalt an sulfamethoxazol und trimethoprim
DE1901915C3 (de) Arzneimittel auf der Basis von a -Aminobenzylpenicillintrihydrat

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8328 Change in the person/name/address of the agent

Free format text: HENKEL, G., DR.PHIL. FEILER, L., DR.RER.NAT. HAENZEL, W., DIPL.-ING., PAT.-ANW., 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee